Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06810180 · ClinicalTrials.gov registry record · NA

Examination of the Dynamic Relationships of Sleep, Physical Activity, and Circadian Rhythmicity With Neurobehavioral Heterogeneity in ADHD

A NA study of Sleep and Physical Activity, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
2
Study locations

NCT06810180: Recruiting NA study of Sleep and Physical Activity, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

NCT06810180 is a NA study of Sleep and Physical Activity that is actively recruiting participants, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 200 participants, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06810180, a NA study of Sleep and Physical Activity, is actively recruiting participants, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
2
Study locations

Study Summary

Attention deficit/hyperactivity disorder (ADHD) can present differently in individuals, with some individuals having difficulty with attentional control, hyperactivity, impulsivity, emotion dysregulation, and/or neurobehavioral functioning. The factors contributing to these different presentations remain unclear, but altered patterns of physical activity, sleep, and circadian rest/activity rhythms may play a key role. The goal of this study is to leverage wearable technology (i.e., a wristband) to investigate the relationships between physical activity during the day, sleep patterns and disturbances, and 24-hour circadian rest/activity rhythms with differences in ADHD symptoms, emotion dysregulation, and related brain and behavioral features of attention-deficit/hyperactivity disorder (ADHD). The investigators hope this study will help improve assessment and intervention for individuals with ADHD by understanding how these factors relate to ADHD symptom expression and associated brain differences in ADHD. Participants taking stimulant medication must withhold stimulant medication 24 hours before their research appointment and the morning of their research appointment. Stimulant medication may be restarted after the appointment is complete. Participation in this study will require children to complete an initial 2-hour research appointment, two (2) weeks of activity and sleep monitoring at home using a wearable wristband and answering questions sent to a smartphone, and a second 4-hour research appointment after the 2-week period. During the first research appointment, children will complete a cognitive assessment and a practice magnetic resonance imaging (MRI) scan. Parents/legal guardians will participate in the 30-45-minute sleep device training session with one of the research staff. During the two weeks of activity/sleep monitoring at home, parents and children will answer questions about their sleep routine, ADHD symptoms, and emotional responding each mor

Primary Outcome

Using an actigraph, this study will collect daily physical activity levels of children. The actigraphic measure, total activity counts (TAC), will capture the number of times a child engages in periods of physical activity during the day and night.

Interventions

  • BEHAVIORAL Go/No-Go Task
  • BEHAVIORAL Delay discounting task
  • BEHAVIORAL Mirror Tracing Persistence Task
  • BEHAVIORAL Spatial Span
  • BEHAVIORAL Stop Signal Task

Study Locations (2)

Maryland

  • Hugo W. Moser Research Institute at Kennedy Krieger - Baltimore
  • Kennedy Krieger Institute - Baltimore

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2025-06-17
Est. Completion 2031-03-31
Phase NA

What NCT06810180 shows while recruiting

NCT06810180 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (95% lower).

The record links to 3 conditions, with Sleep appearing as the primary indexed condition, and to 5 interventions - of which Go/No-Go Task is the first listed.

NCT06810180 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT06810180 about?

NCT06810180 is a clinical study titled "Examination of the Dynamic Relationships of Sleep, Physical Activity, and Circadian Rhythmicity With Neurobehavioral Heterogeneity in ADHD". Attention deficit/hyperactivity disorder (ADHD) can present differently in individuals, with some individuals having difficulty with attentional control, hyperactivity, impulsivity, emotion dysregulation, and/or neurobehavioral functioning. The factors contributing to these different presentations r...

What is the current status of trial NCT06810180?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-06-17. Estimated completion is 2031-03-31.

What conditions does trial NCT06810180 study?

This clinical trial studies the following conditions: Sleep, Physical Activity, Attention Deficit Hyperactivity Disorder (ADHD).

What interventions are being tested in trial NCT06810180?

The interventions under investigation include: Go/No-Go Task (BEHAVIORAL), Delay discounting task (BEHAVIORAL), Mirror Tracing Persistence Task (BEHAVIORAL), Spatial Span (BEHAVIORAL), Stop Signal Task (BEHAVIORAL).

Who is sponsoring clinical trial NCT06810180?

This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06810180 being conducted?

This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06810180's enrollment target sits among peer trials

200 27th of 151 higher than 121 of 151 other Sleep trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sleep trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06810180, the US trial registry maintained by the National Library of Medicine. NCT06810180 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.